Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma
|
168 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Carcinoma of lung
|
1204 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.100 | 1.000 | 13 | 2009 | 2018 | ||||
cervical cancer
|
268 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.010 | 1 | 2012 | 2012 | |||||
Cervix carcinoma
|
283 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.010 | 1 | 2012 | 2012 | |||||
Cleft palate with cleft lip
|
43 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Malignant neoplasm of lung
|
1142 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.100 | 1.000 | 13 | 2009 | 2018 | ||||
Malignant neoplasm of prostate
|
1082 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Malignant Neoplasms
|
1641 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.020 | 1.000 | 2 | 2013 | 2017 | ||||
Malignant tumor of cervix
|
245 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.010 | 1 | 2012 | 2012 | |||||
Nasopharyngeal carcinoma
|
320 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.020 | 1.000 | 2 | 2012 | 2016 | ||||
Neoplasms
|
1644 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.020 | 1.000 | 2 | 2012 | 2016 | ||||
Non-Small Cell Lung Carcinoma
|
712 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.020 | 0.500 | 2 | 2009 | 2013 | ||||
Primary malignant neoplasm
|
1374 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.020 | 1.000 | 2 | 2013 | 2017 | ||||
Primary malignant neoplasm of lung
|
981 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.100 | 1.000 | 13 | 2009 | 2018 | ||||
Prostate carcinoma
|
1168 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Small cell carcinoma of lung
|
125 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Squamous cell carcinoma
|
257 | 0.716 | 0.320 | 5 | 1320607 | non coding transcript exon variant | C/T | snv | 0.33 | 0.38 | 0.010 | 1.000 | 1 | 2010 | 2010 |